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Skin comprises many cell types that are character-
ized by high biosynthetic activity and increased
energy turnover. The creatine kinase system, consist-
ing of creatine kinase isoenzymes and creatine trans-
porter, is known to be important to support the high
energy demands in such cells. We analyzed the pres-
ence and the localization of these proteins in murine
and human skin under healthy and pathologic condi-
tions, using immunoblotting and confocal immuno-
histochemistry with our recently developed speci®c
antibodies. In murine skin, we found high amounts
of brain-type cytosolic creatine kinase coexpressed
with lower amounts of ubiquitous mitochondrial
creatine kinase, both mainly localized in suprabasal
layers of the epidermis, different cell types of hair
follicles, sebaceous glands, and the subcutaneous
panniculus carnosus muscle. With exception of seba-
ceous glands, these cells were also expressing creatine
transporter. Muscle-type cytosolic creatine kinase
and sarcomeric mitochondrial creatine kinase were
restricted to panniculus carnosus. Immediately after
wounding of murine skin, brain-type cytosolic crea-
tine kinase and a creatine transporter-subspecies
were transiently upregulated about 3-fold as seen in
immunoblots, whereas the amount of ubiquitous
mitochondrial creatine kinase increased during days
10±15 after wounding. Healthy and psoriatic human
skin showed a similar coexpression pattern of brain-
type cytosolic creatine kinase, ubiquitous mitochon-
drial creatine kinase, and creatine transporter in this
pilot study, with creatine transporter species being
upregulated in psoriasis. Key words: creatine kinase/
creatine transporter/cutaneous wound repair/IgY/psoriasis.
J Invest Dermatol 118:416±423, 2002
M
any cells and tissues such as sperm cells, muscle, or
brain use metabolically inert creatine and phos-
phocreatine together with isoenzymes of creatine
kinase (CK) to cope ef®ciently with high and/or
alternating adenosine triphosphate (ATP) re-
quirements (reviewed in Wallimann et al, 1992; Schlattner et al,
1998). CK catalyzes the reversible transphosphorylation between
ATP and phosphocreatine. The enzyme is therefore able to stock
the free energy of ATP in the form of phosphocreatine and, vice
versa, to use phosphocreatine to replenish cellular ATP pools.
Expression of CK isoenzymes in vertebrates is tissue and
compartment speci®c. Two dimeric cytosolic isoenzymes, MM-
CK (muscle-type) and BB-CK (brain-type) and two octameric
mitochondrial isoenzymes, sMtCK (sarcomeric) and uMtCK
(ubiquitous) are encoded by separate nuclear genes. Cytosolic and
mitochondrial isoenzymes are usually coexpressed, with MM-CK
and sMtCK found in skeletal muscle, and BB-CK and uMtCK in
brain, smooth muscle, and many other organs and tissues. The
interplay between cytosolic and mitochondrial CK isoenzymes, the
CK/phosphocreatine circuit, provides an ef®cient energy buffer
and energy shuttle system that plays a pivotal role in cellular energy
supply and energy homeostasis (Bessman and Carpenter, 1985;
Wallimann et al, 1992; Schlattner et al, 1998). The creatine
transporter (CRT) is an important component of the CK/
phosphocreatine system, responsible for the Na+/CL±dependent
creatine uptake into the cell (Guimbal and Kilimann, 1993; Sora et
al, 1994; Saltarelli et al, 1996; Dai et al, 1999), leading to
intracellular total creatine (creatine + phosphocreatine) concentra-
tions of up to 40 mm.
CK has been detected in many different epithelia. This may be
due to manifold energy requirements of these cells, including high
proliferation rates, active ion pumps, and transport processes.
Where examined, a coexpression of BB-CK and uMtCK was
observed (Keller and Gordon, 1991), with BB-CK being the
predominant isoenzyme, by far; however, the abundance of CK in
epithelia varies considerably. Certain organs contain epithelia that
are highly enriched in CK, e.g., the electric organ of Torpedo
(Barrante et al, 1983), where also CRT was detected (Guimbal and
Kilimann, 1994), the choroid plexus (Kaldis et al, 1996), kidney
(Ikeda, 1988), the adult eye lens (Friedman et al, 1989), or prostate
(Silverman et al, 1979). Lower amounts of BB-CK were found in
many epithelia of the urogenital system and the digestive tract
(Wold et al, 1981; Gordon and Keller, 1992; Sistermans et al, 1995).
In epithelia of the respiratory tract, only traces of CK were
observed (Braegger, Schlattner, Utiger, Wallimann, and
Sennhauser, unpublished data).
Although representing one of the largest epithelia, skin has not
yet been analyzed in detail for CK isoenzymes and their tissue
localization. Furthermore, no information at all has been published
on the presence and localization of CRT in this tissue. CK activity
was reported in extracts of normal and psoriatic human skin, skin
tumors, and keratinocyte cell cultures (Zemtsov et al, 1994a) and
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BB-CK was localized in human skin epidermis and blister ¯uid
(Kiistala et al, 1989), as well as in murine skin (Chida et al, 1990;
Sistermanns et al, 1995). Phosphocreatine in skin has been detected
by high-performance liquid chromatography (Zemtsov et al, 1993)
and more unambiguously by high-resolution 31P-NMR imaging
(Bohning et al, 1996), indicating a functional phosphocreatine/CK
system in this tissue. In addition to basic cellular functions of skin,
the CK/phosphocreatine system may also be involved in repair
processes like wound healing or in hyperproliferative skin disease,
such as psoriasis. During wound healing, enzymes of the de novo
nucleotide biosynthetic pathway (Gassmann et al, 1999) are highly
upregulated in the wounded epidermis, re¯ecting the elevated need
for nucleoside triphosphates in cellular energy transduction, nucleic
acid synthesis, and biosynthetic pathways in general. Similar
conclusions may be true for psoriasis, where highly elevated
phosphocreatine levels point to an especially active CK/phospho-
creatine system (Zemtsov et al, 1994b). Psoriasis is an in¯ammatory
skin disease that is characterized by increased angiogenesis and
hyperthickening of the epidermis due to an imbalance in
keratinocyte proliferation and differentiation (Kadunce and
Krueger, 1995).
In this study, we set out to identify and localize CK and CRT
species in healthy and diseased skin, as well as during the wound
healing process. Using highly speci®c antibodies for immunoblot-
ting and immunohistochemistry with ¯uorescence and confocal
microscopy, we could show coexpression of BB-CK, uMtCK, and
CRT in several speci®c cell types and changes in protein levels
during wound healing and in psoriatic skin disease.
MATERIALS AND METHODS
Proteins and antibodies against CK isoenzymes CK isoenzymes
were expressed in Escherichia coli and puri®ed as described earlier (Eder et
al, 1999; Schlattner et al, 2000). Final gel ®ltration chromatography on
Superose 12 (Amersham Pharmacia Biotech, Uppsala, Sweden) was used
to obtain highly pure protein. Polyclonal antibodies against human
sMtCK and uMtCK were produced in rabbits by standard procedures.
Rabbits were injected subcutaneously with 200 mg aliquots of protein in
complete Freund's adjuvant, followed by three boosts, every 3 wk, in
incomplete Freund's adjuvant. Immune sera were collected 3, 5, and
7 wk after the last immunization. Polyclonal antibodies against human
BB-CK were obtained from egg yolk of immunized SHAVER outdoor
579 hens. Forty micrograms of BB-CK in complete Freund's adjuvant
were injected into the pectoral muscle of each hen, followed after 8 wk
by one boost of 40 mg BB-CK in incomplete Freund's adjuvant. Eggs
were collected after one further week and stored at 4°C. A simple water
dilution method was used to separate yolk plasma proteins from the
granules and lipids (Akita and Nakai, 1993; Kokko and KaÈrenlampi,
1998). The egg yolk was separated, washed and diluted with 9 vol. of
distilled water. The emulsion was adjusted to pH 5.0, incubated
overnight at 4°C, and centrifuged at 8000 3 g for 25 min at 4°C.
Proteins containing egg immunoglobulins (IgY) were precipitated with
sodium acetate (200 g per l) at room temperature and resuspended in 5±
8 ml Tris-buffered saline (TBS) per egg. BB-CK-speci®c IgY were
further puri®ed by af®nity chromatography, using human BB-CK
coupled to N-hydroxysuccinimide-ester activated methacrylate
copolymer (Af®-Prep 10, Bio-Rad, Reinach, Switzerland). Bound IgY
was eluted by 0.2 m glycine, 0.15 m NaCl, pH 2.3, neutralized in 1 m
Tris±HCl buffer, pH 8.0, and concentrated by ultra®ltration (Centriplus
YM-100, Millipore, Bedford, MA). For extended storage, IgY
preparations were adjusted to 40% glycerol and stored at ± 20°C. Purity
and recovery of IgY were monitored by 8% nonreducing standard
sodium dodecyl sulfate (SDS)±polyacrylamide gels and Coomassie
staining.
Wounding of mice and preparation of wound tissue BALB/C mice
were obtained from RCC (FuÈllinsdorf, Switzerland). They were housed
and fed according to Swiss federal guidelines, and all procedures were
approved by the local authorities. Full thickness excisional wounds were
generated as described earlier (Werner et al, 1994). Brie¯y, mice (8±
12 wk of age) were anesthetized with a single intraperitoneal injection of
ketamine/xylazine. The hair on the animals' back was shaved and the
skin was wiped with 70% ethanol. Four full-thickness excisional wounds
(5 mm diameter, 3±4 mm apart, two wounds on each side of the spinal
cord) were generated on the back of each animal by excising skin and
panniculus carnosus. The wounds were allowed to dry to form a scab.
The back skin that was excised upon generation of the wounds served as
control (0 d, healthy skin). Animals were killed at different time points
after injury (1±14 d). For tissue extracts, the wounds on the left side,
including 2 mm of the epithelial margins were isolated and immediately
frozen in liquid nitrogen. Wound tissue of several animals was pooled
and soluble proteins were extracted in lysis buffer containing NP-40 and
urea as described elsewhere (Werner et al, 1993; Wakita and Takigawa,
1999). For immunohistochemistry, the complete wounds on the right
side were isolated, bisected, ®xed in 95% ethanol/1% acetic acid, and
embedded in paraf®n.
Human tissue samples Human tissue samples (brain, kidney, heart,
and skeletal muscle) were obtained from Dr V. Adams (University of
Leipzig, Germany), and soluble protein and mitochondria-enriched
pellets were extracted according to Schlegel et al (1988). Human skin
biopsies of three healthy and three psoriasis patients containing epidermis
and dermis of upper or lower extremities were obtained from Dr. C.
Mauch (University of Cologne, Germany; see Hanselmann et al, 2001).
They were immediately frozen without ®xing procedure. Protein
extracts were prepared as described previously (Werner et al, 1993).
SDS±polyacrylamide gel electrophoresis and immunoblots Samples
were separated by standard 12% SDS±polyacrylamide gel electrophoresis
and electrotransferred by semidry blotting (Trans Blot SD, Bio-Rad) on
to nitrocellulose (0.45 mm pore size; Schleicher & SchuÈll, Dassel,
Germany) according to the manufacturer's instructions. Loading of the
blots was veri®ed by a reversible staining with Ponceau S (0.2% in 0.3%
trichloroacetic acid (TCA); Serva, Heidelberg, Germany). Membranes
were blocked with 4% fat-free milk powder in TBS (20 mm Tris±HCl,
pH 7.5, 150 mm NaCl), incubated for 1 h with CK or CRT immune
sera (see below, 1:1000 dilution in blocking buffer) or af®nity-puri®ed
puri®ed anti-BB-CK IgY (1:500 dilution in blocking buffer), washed
three times in TBS, incubated 1 h with peroxidase-coupled secondary
antibodies (1:3000 dilution in blocking buffer), either goat anti-rabbit
IgG (Nordic, Lausanne, Switzerland) or rabbit anti-chicken IgY (Jackson
ImmunoResearch, West Grove, PA) and ®nally washed three times with
TBS. Blots were developed with enhanced chemiluminescence substrate
(NEN, Zaventem, Belgium) and exposed to X-ray ®lm (1±60 s) or
analyzed with a digital imager (Kodak Image Station; Kodak, Rochester,
NY).
Immunostaining Ethanol/acetic-acid ®xed and paraf®n wax
embedded samples of mouse skin and non®xed samples of human skin
were cut with a microtome into 5±7 mm thin sections. Paraf®n-
embedded sections were deparaf®nized, rehydrated, and incubated in
0.05% sodium borohydride (NaBH4) in phosphate-buffered saline (PBS)
to quench auto¯uorescence. After rinsing with PBS, sections were
permeabilized with 0.2% Triton-X-100 for 10 min, followed by a wash
in PBS. Frozen sections stored at ±80°C were directly ®xed in acetone at
±20°C for 10 min, washed three times in PBS, and blocked for 30 min
with 5% goat serum albumin/1% bovine serum albumin (BSA). Sections
were then incubated overnight at 4°C in a moist chamber with different
primary antibodies, diluted in PBS, containing either 0.2% Tween-20
(polyoxyethylenesorbitan monolaureate) and 1% BSA (paraf®n-
embedded) or 5% goat serum albumin/1% BSA (frozen sections).
Polyclonal primary antibodies were (dilution in brackets): af®nity-
puri®ed chicken IgY against human BB-CK (lot 23±1; 1:100),
preimmune IgY (1:100), and rabbit anti-sera against human sMtCK (lot
r3i3; 1:200), human uMtCK (lot r7i3; 1:200), chicken MM-CK (lot
1985; 1:100), and rat CRT C-terminus (lot 75898; 1:100), as well as the
corresponding rabbit preimmune sera (same dilutions). Monoclonal
primary antibodies were (dilution in brackets): anti-keratin 10 and
keratin 14 (Dako Diagnostics AG, Zug, Switzerland; 1:100); anti-CD31
(Dako; prediluted), anti-F4/80 (Serotec, Oxford, GB; 1:100), and anti-
wheat germ agglutinin (Dako; 1:200). After washing four times in PBS/
0.1% Tween-20, sections were incubated for 1 h at room temperature in
a moist chamber with secondary antibody diluted in PBS, containing
either 0.1% Tween-20 and 12% BSA (paraf®n embedded) or only 1%
BSA (frozen sections). Secondary antibodies were Cy3-conjugated rabbit
or donkey anti-chicken IgY (Jackson ImmunoResearch; 1:500), Texas
Red-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch;
1:100), Cy3- or ¯uorescein isothiocyanate-conjugated goat anti-rabbit or
anti-mouse IgG (Pierce, Rockford, IL; 1:200±1:500). Sections were
again washed four times in PBS, including 0.1% Tween-20 and 0.02%
sodium azide, and ®nally mounted in an anti-fading solution (30 mm
Tris-HCl, pH 9.5, 70% (vol/vol) glycerol, and 240 mm N-propyl-
gallate).
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Microscopy Fluorescence images of sections were recorded on a
¯uorescence microscope (Carl Zeiss, Oberkochen, Germany) with an
attached CCD camera (Hamamatsu 3CCD, Hamamatsu, Herrsching,
Germany) using Achrostigmat 53/0.12 or Plan-Neo¯uoar 103/0.3
objectives. Confocal images were recorded with a Leica inverted
microscope DM IRB/E connected to a Leica true confocal scanner TCS
NT and Leica PL APO 1003/1.4 oil or PL APO 633/1.4 oil
immersion objectives. The system was equipped with an argon/krypton
mixed gas laser. Image processing was done on a Silicon Graphics
workstation using Imaris software (Bitplane AG, Zurich, Switzerland)
and Corel Photo-Paint (Corel, Ottawa, Canada).
RESULTS
Speci®city of polyclonal antibodies For immuno-
histochemical studies, we have raised polyclonal antibodies
against heterologously expressed and highly puri®ed human CK
isoenzymes in rabbit and chicken. Rabbit anti-sera against human
sMtCK and uMtCK speci®cally detected mitochondrial
isoenzymes, with relatively high selectivity for the corresponding
isoenzyme. Anti-uMtCK anti-sera (Fig 1a) visualized human
uMtCK in mitochondria-enriched brain extracts (Fig 1a, lane 2)
and puri®ed uMtCK (Fig 1a, lane 5), with some cross-reactivity
with abundant sMtCK in muscle (Fig 1a, lane 4) and pure sMtCK
(Fig 1a, lane 6). Anti-sMtCK anti-sera (Fig 1b) reacted mainly
with human sMtCK in mitochondria-enriched muscle extracts
(Fig 1b, lane 4) or puri®ed sMtCK (Fig 1b, lane 6), with minor
cross-reaction with pure uMtCK (Fig 1b, lane 5). Antibodies did
neither cross-react with other proteins in several human tissue
extracts nor with cytosolic CK (Fig 1, lanes 1±4), except for a faint
cross-reactivity of sMtCK antibodies with cytosolic MM-CK in
human muscle extracts, running just below the sMtCK band
(Fig 1b, lane 3); however, no signal was observed with chicken
MM-CK (Fig 1b, lane 8).
Chicken IgY against heterologously expressed and puri®ed
human BB-CK were isolated from egg yolk and af®nity-puri®ed to
eliminate any cross-reactivity with other proteins (Fig 2a). The
®nal IgY preparation only reacted with tissue containing BB-CK,
such as brain (Fig 2b, lane 1) and kidney (Fig 2b, lane 2), as well as
with puri®ed human BB-CK (Fig 2b, lanes 7, 8). Rabbit
polyclonal antibodies against the C-terminal part of rat CRT
have already been described elsewhere (Guerrero-Ontiveros and
Wallimann, 1998). All antibodies reacted in a similar way with CK
and CRT from rat and mouse tissue extracts (data not shown).
CK isoenzymes and CRT in murine skin Sections of
paraf®n-embedded murine skin samples were analyzed by
immunohistochemistry for the presence of different CK
isoenzymes and CRT (Fig 3, left panel). Fluorescence
microscopy revealed strong and cell-type speci®c expression of
BB-CK, uMtCK, and CRT (Figs 3c, f, l) in epidermis, hair
follicles, and to a lesser extent in panniculus carnosus, the
subcutaneous striated muscle. Dermis and subcutis (adipose
tissue) stained much weaker for BB-CK, uMtCK, and CRT.
Signals for sMtCK (Fig 3i) and MM-CK (data not shown)
were restricted to panniculus carnosus and therefore not due to
cross-reactivity with uMtCK or BB-CK. In 3 d old murine skin
wounds, the hyperproliferative epithelium at the wound edge
stained especially strong for BB-CK, uMtCK, and CRT (Fig 3,
central panel). Control incubation with preimmune IgY and
Figure 1. Immunoreactivity of anti-MtCK rabbit serum
antibodies. Immunoblots probed with polyclonal rabbit antibodies
against (a) human uMtCK and (b) human sMtCK. Lanes: (1) human
brain, soluble proteins (24 mg protein); (2) human brain, mitochondria-
enriched pellet (24 mg); (3) human muscle, soluble protein (24 mg); (4)
human muscle, mitochondria-enriched pellet (24 mg); (5) human uMtCK
(1 mg); (6) human sMtCK (1 mg); (7) human BB-CK (3 mg); and (8)
chicken MM-CK (3 mg).
Figure 2. Puri®cation and immunoreactivity of anti BB-CK IgY
antibodies. (a) Nonreducing SDS±polyacrylamide gel electrophoresis of
IgY preparations from chicken egg yolk (for details see Materials and
Methods). Lanes: (1) supernatant of diluted preimmune egg yolk; (2)
supernatant of diluted immune egg yolk; further processing of immune
egg IgY: (3) dissolved pellet of sodium sulfate precipitation; (4) sterile
®ltered IgY preparation; (5) IgY bound to BB-CK af®nity column,
stabilized with 0.5 mg per ml BSA; (6) IgY in ¯ow-through of BB-CK
af®nity column. Note: lane 5 only shows the BSA band (*), the low
amounts of IgY do not stain. (b) Reactivity of af®nity-puri®ed IgY with
human tissue extracts and pure CK. Lanes: (1) brain (20 mg); (2) kidney
(20 mg); (3) heart muscle (20 mg); (4) skeletal muscle (20 mg); (5) human
uMtCK (3 mg); (6) human sMtCK (3 mg); (7) human BB-CK (3 mg); (8)
human BB-CK (0.3 mg); (9) rabbit MM-CK (3 mg). Note the complete
absence of cross-reactivity with any other protein or CK isoenzyme.
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preimmune rabbit sera (Fig 3, right panel) showed only very
faint background staining, con®rming the low cross-reactivity of
the applied antibodies in mouse tissue.
Confocal microscopy of murine skin sections revealed expression
of BB-CK in speci®c cell types (Fig 4, left panels). In murine
epidermis, the suprabasal layers costained with keratin 10 (Fig 4b)
rather than the basal layers costained with keratin 14 (Fig 4a) were
strongly positive for BB-CK. As evident in Fig 4b, BB-CK was
mainly located in the cell periphery near or at the plasma
membrane, showing a particulate pattern. In the dermis, the
majority of cells in the pilosebaceous apparatus were positive for
BB-CK (Fig 4e, f, i). The enzyme was especially abundant in the
sebaceous glands and speci®c parts of the hair follicle, including the
dermal hair papilla (Fig 4e) and the inner root sheath, which is the
cell layer surrounding the growing hair (Fig 4e, f, i). By contrast,
the outer root sheath costained with keratin 14 is nearly devoid of
BB-CK (Fig 4f). Strong staining was also detectable in endothelial
cells of blood vessels in the subcutis and in the panniculus carnosus
(Fig 4j). Among the CK-positive cells in the granulation tissue of
wounds we identi®ed endothelial cells and macrophages, using
costaining with CD-31 and F4/80, respectively (data not shown;
Austyn and Gordon, 1981). Staining for uMtCK in all these
sections was nearly identical to BB-CK (data not shown, compare
to Fig 3f, g).
Figure 3. Distribution of CK isoenzymes in
healthy and wounded murine back skin. (a, b)
Phase contrast and (c±n) immuno¯uorescence
microscopy images of 7 mm sections of healthy
skin (left panel) and 3 d full thickness excisional
wounds (middle and right panel; overviews of the
left half of a wound are shown). Sections were
stained for (c, d) BB-CK (f, g) uMtCK (i, j)
sMtCK, and (l, m) CRT. The speci®city of the
applied antibodies was veri®ed with (e)
preimmune IgY or (h±n) the corresponding
preimmune sera. Secondary antibodies were Cy3-
conjugated for BB-CK (c±k; red channel) and
¯uorescein isothiocyanate-conjugated for CRT
(l±n, green channel). Sections indicated in (a, b)
are given as immuno¯uorescence image in (c, d).
For details see Materials and Methods. D, dermis; E,
epidermis; ES, eschar; G, granulation tissue; HF,
hair follicle; HE, hyperproliferative epidermis; PC,
panniculus carnosus; SC, subcutis. Scale bars: 50 mm.
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Most cells strongly expressing BB-CK and uMtCK were also
positive for CRT (Fig 4, right panels). A strong signal was
observed in different layers of the epidermis (Fig 4c, d), the dermal
hair papilla (Fig 4g), the inner root sheath of the hair follicle
(Figs 4g, h), and the panniculus carnosus. In contrast to CK
isoenzymes, CRT was less abundant in sebaceous glands (Fig 4g).
CRT showed only faint staining at the cell periphery as indicated
by a slight overlapping with the extracellular marker wheat germ
agglutinin (yellow in Fig 4d, l). Most CRT was not related to
plasma membrane, but showed a particulate pattern inside the cell
as observed in epidermis (Fig 4d) or was abundantly present in the
whole cell body except the nucleus as seen in hyperproliferative
epithelium (Figs 4k, l).
CK isoenzymes and CRT protein during cutaneous wound
repair As CK and CRT were detected in newly regenerating
tissue after wounding, we examined the time course of these
proteins in wound tissue extracts by immunoblotting (Fig 5). The
intensity of the signals suggested that at least 10 times more BB-CK
is present in skin tissue as compared with the other proteins
examined (Fig 5a). After wounding, the amount of BB-CK
increased rapidly in an early response as soon as 12 h after injury
(data not shown). After 24 h, at least three times more BB-CK
protein was present compared with control, but then declined
rapidly to reach control levels after 7 d. The amount of uMtCK
remained roughly constant during this time period, but increased
transiently to a variable degree during days 10±15 after wounding.
MM-CK and sMtCK were present, but disappeared during the
initial phase of wound healing most likely due to excision of the
panniculus carnosus.
Polyclonal antibodies against N- and C-terminal peptides of
CRT recognized up to three different protein bands in mouse
tissue extracts separated by SDS±polyacrylamide gel electrophoresis
(Fig 5 and unpublished data; see also Guerrero-Ontiveros and
Wallimann, 1998; Neubauer et al, 1999; Tran et al, 2000; Murphy
et al, 2001). These bands migrate at an apparent molecular weight
of about 55, 65, and 70 kDa (CRT55, CRT65, and CRT70;
Fig 5). After wounding, CRT55 and CRT70 did not change, but
CRT65 showed a transient increase during days 1±3. This
correlated very well with the above-described upregulation of
BB-CK. Later, during days 5±10, all CRT bands showed a
temporal downregulation before returning to control levels at day
13.
CK isoenzymes and CRT in healthy and psoriatic human
skin Immunohistochemistry of human skin revealed an overall
expression pattern of the CK system that is similar to mice (Fig 6);
however, BB-CK intensely stained the entire epidermis, including
apparently also the more basal layers. In addition, the particulate
pattern at or near the plasma membrane was more pronounced than
in murine skin (Fig 6a±c). uMtCK colocalized with BB-CK, but
the staining was weaker compared with murine skin (data not
shown). As psoriasis, a hyperproliferative in¯ammatory skin disease,
often shows similarities to wounded skin, we analyzed the
expression of the CK system in a pilot study involving three
patients and three healthy volunteers. BB-CK (Fig 6d±f), uMtCK
and CRT (data not shown) were coexpressed across the entire,
much thicker epidermal layers, suggesting a strong expression of
these proteins in psoriatic skin. Immunoblotting results normalized
to total protein concentration con®rmed the upregulation of
Figure 4. Details of BB-CK and CRT localization in murine back skin. Immuno¯uorescence confocal microscopy images of 7 mm sections
either stained for BB-CK (af®nity-puri®ed IgY) using Cy3 conjugated secondary antibody (red channel, left panels), or stained for CRT (rabbit
antibodies raised against the CRT C-terminus) using ¯uorescein isothiocyanate-conjugated secondary antibody (green channel, right panels). (a±d)
epidermis and dermis, double stained (a)with keratin-14 (blue channel, basal epidermal layer), (b) keratin-10 (blue channel, suprabasal epidermal layers),
or (d) wheat germ agglutinin (red channel, extracellular matrix); (e±i) hair follicle and connected glands (pilosebaceous apparatus) (e, g, i) longitudinal
sections (f, h) transverse sections just above the hair bulb, in (f ) double stained with keratin-14 (blue channel); (j) subcutis with panniculus carnosus; (k,
l) hyperproliferative epithelium at the wound edge, in (l ) double stained with wheat germ agglutinin (red channel, extracellular matrix). Note the green
auto¯uorescence of the hair in (e) and the BB-CK staining of suprabasal epidermal layers and the inner root sheath in (b) and (f), respectively. BV,
blood vessel; D, dermis; DHP, dermal hair papilla, E, epidermis; ORS, outer root sheath; H, hair; HF, hair follicle; HE, hyperproliferative epithelium,
IRS, inner root sheath; PC, panniculus carnosus; SC, subcutis; SG, sebaceous gland. Scale bars: 10 mm.
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CRT55 and CRT65 subspecies in psoriatic skin samples of all three
patients as compared with healthy controls (Fig 7). In two
individuals, antibodies against CRT N- and C-termini
recognized an additional band at 115 kDa, which is occasionally
also observed in mouse tissues and may represent a nondissociated
dimeric CRT species. In case of CK isoenzymes, a very strong
variability among individuals made it impossible to detect
statistically signi®cant changes in expression levels with the given
number of samples.
DISCUSSION
In this study we have analyzed the CK/phosphocreatine system in
murine and human skin. Using largely isoenzyme-speci®c anti-
bodies, we could show that cytosolic and mitochondrial CK, as
well as CRT, are speci®cally coexpressed in many cell types of
murine and human skin. In addition, we found upregulation of
BB-CK and a CRT-subspecies after wounding of murine skin and
increased abundance of CRT species in psoriatic human skin.
Suitable antibodies against the ubiquitous CK isoenzymes (BB-
CK and uMtCK) for histologic studies with mouse tissues were not
available so far. Our new polyclonal antibodies generated in rabbits
against recombinant human uMtCK and sMtCK, however, are
MtCK-speci®c, applicable to different species, and show only very
low cross-reactivity with the corresponding other MtCK iso-
enzyme, as also demonstrated in two recent studies (Tarnopolsky et
al, 2001; Kornacker et al, 2001). Af®nity-puri®ed anti-BB-CK IgY
from chicken egg yolk speci®cally recognized BB-CK in several
human tissues, without cross-reactivity to other proteins than BB-
CK in human skeletal muscle, brain, and kidney. This compares
very well with a monoclonal anti-BB-CK antibody such as 21E10
(Sistermanns et al, 1995). Although these monoclonals are very
useful, they present some important limitations for histologic
studies in mice. Many tissues give a background signal in
immuno¯uorescence applications due to reaction of secondary
antibodies with endogenous mouse IgG. Furthermore, some tissues
known to contain BB-CK showed a very low signal, indicating that
the epitope recognized by the monoclonals is possibly hidden
(Sistermans et al, 1995). As we can demonstrate in murine skin,
polyclonal IgY can overcome these drawbacks. Chicken IgY can be
used on mouse tissue for detection at a high level of sensitivity
without problems of background staining. In addition, IgY
recognize a variety of different epitopes due to their polyclonal
origin and the phylogenetic distance between chicken and human,
mouse or rat. A further advantage of IgY is their cheap and harmless
production in egg yolk, giving a high titer of antibodies in a rather
short time span.
Using these antibodies to analyze murine and human skin by
immunoblotting and immuno¯uorescence confocal microscopy,
Figure 6. Distribution of BB-CK in healthy
and psoriatic human skin. Phase contrast (left
panel) and immuno¯uorescence microscopy
images (central and right panels) of 5 mm sections
of healthy (a±c) and psoriatic skin (d±f ) stained for
for BB-CK using Cy3 conjugated secondary
antibodies. The sections indicated in (b, e) are
enlarged in (c, f ). Scale bars: 50 mm.
Figure 5. CK isoenzymes and creatine transporter in murine skin
during wound healing. (a) Immunoblots of skin extracts before (day 0)
and at different time points after injury (days 1±13). Samples contained
epidermis, dermis, adipose tissue, and, where present, panniculus
carnosus. 40 mg of total protein were applied to each lane and equal
loading was veri®ed by Ponceau S staining and quantitation on a Kodak
image station. Blots were developed as described in detail in Materials and
Methods. For immunoluminescence detection, blots were exposed to X-
ray ®lm for 1 s (BB-CK) or 60 s (MM-CK, uMtCK, sMtCK, CRT). Mr
for bands revealed with antibodies against the CRT C-terminus is
indicated. (b) Relative amount of BB-CK 6 SD (n = 4) in skin samples
(shown in a), quanti®ed by exposure of the immunoluminescent blots in
a Kodak image station. BB-CK before injury (day 0) was taken as 100%.
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we could mostly detect coexpression of BB-CK and uMtCK
together with CRT. High expression of these proteins was
con®ned to speci®c cell types that are characterized by especially
high metabolic rates and energy turnover. The suprabasal layers of
the epidermis and cells of the inner root sheath in hair follicles have
high biosynthetic activity, characterized by synthesis of keratins and
of the corni®ed envelope. Hyperproliferative epithelium and the
hair papilla are actively dividing tissues involved in wound healing
and hair growth, respectively. Only CK expression in sebaceous
glands was not paralleled by a high amount of CRT protein.
Suprabasal epithelial layers of the hyperproliferative epithelium not
only contained most of the CK and CRT, but are also highly
expressing key enzymes involved in nucleotide biosynthesis
(Gassmann et al, 1999), thus emphasizing the highly active nucleic
acid synthesis and energy metabolism in these cells. MM-CK and
sMtCK were restricted to the subcutaneous striated muscle
panniculus carnosus and absent in skin, thus not con®rming earlier
detection of MM-CK in epidermis, which was rather due to
contamination by muscle ®bers (Zemtsov et al, 1994a). In addition,
immunohistochemical signals for BB-CK and uMtCK were
observed in this muscle. Although a minor part of the uMtCK
signal may be due to cross-reactivity with sMtCK (see Fig 1a), the
data suggest a coexpression of all four CK isoenzymes in panniculus
carnosus.
Co-localization of creatine uptake together with mitochondrial
and cytosolic CK activity in metabolically highly active cells and
the presence of an intracellular phosphocreatine pool (Zemtsov et
al, 1993; Bohning et al, 1996) clearly indicate a functional CK/
phosphocreatine shuttle (Wallimann et al, 1992) in these cells;
however, as judged from immunoblots, CK-positive skin cells
contain much more cytosolic BB-CK than mitochondrial CK. This
is certainly related to the predominantly glycolytic metabolism of
normal and particularly wounded skin (Hunt et al, 1978), with only
a minor contribution of oxidative phosphorylation. The CK/
phosphocreatine-system will therefore predominantly provide a
cytosolic energy buffer, bridging sites of glycolytic activity with
sites of energy consumption. Some of the major energy consuming
sites may be localized at the plasma membrane (e.g., ion pump
ATPases), as indicated by accumulation of BB-CK in the vicinity of
plasma membrane in murine and human skin sections.
Of further importance for the above described CK/phospho-
creatine shuttle are the multiple CRT species detected in
immunoblots (Guerrero-Ontiveros and Wallimann, 1998;
Neubauer et al, 1999; Tran et al, 2000; Murphy et al, 2001). The
three to four proteins recognized by polyclonal antibodies against
CRT C- and N-termini are probably generated by alternative
splicing, secondary modi®cation due to glycosylation and possibly
also dimerization (unpublished data); however, apart from the
origin of these proteins, there is growing evidence for a different
localization of these CRT species. Very recent data suggest that
CRT55 and CRT70 may be at least in part located in
mitochondria (unpublished data). This corresponds very well to
the particulate pattern of CRT in most skin cell types examined. In
vivo biotinylation labeling and creatine uptake experiments indicate
that the third protein, CRT65, is likely representing the intrinsic
plasma membrane CRT, which labels more poorly in immuno-
histochemistry (Murphy et al, 2001). Thus, only part of the
histologically detected CRT would be directly involved in creatine
uptake from the extracellular space, whereas the role of
mitochondrial CRT still remains enigmatic.
Wound healing is a complex process involving in¯ammation,
new tissue formation, and ®nally tissue remodeling (reviewed in
Clark, 1996 and Martin, 1997). Interestingly, both the in¯amma-
tory and the proliferative phase of repair were characterized by
increased levels of BB-CK and CRT65 protein. We could observe
a signi®cant increase of BB-CK and the CRT65 protein during the
very ®rst phase following injury, already after 12 h. This correlates
with the upregulation of key regulatory enzymes in purine and
pyrimidine metabolism such as adenylosuccinate kinase, PRPP
synthetase, and others (Gassmann et al, 1999), most likely triggered
as an early response by keratinocyte growth factor and other
growth factors present in the wound. Thus, the initial phase of
cutaneous wound repair is characterized by nucleotide biosynthesis
and maintenance of high [ATP]/[adenosine diphosphate] ratios by
CK. This also makes BB-CK and CRT65 likely candidates for
regulation by growth factors. Later, during days 10±15 of wound
healing, there is a suspicious rise of uMtCK, correlated with
apoptotic cell elimination and matrix remodeling, including the
redifferentiation into subcutis and dermis in the granulation layer of
the wound. Possibly, these processes rely much more on an
oxidative metabolism, with uMtCK using mitochondrially pro-
duced ATP. The opposite time course of muscle-speci®c cytosolic
MM-CK and mitochondrial sMtCK, disappearing during the initial
wound healing, is most likely due to excision of panniculus
carnosus muscle during the application of wounds and following
regeneration.
Like injured skin, psoriatic skin is characterized by upregulation
of epithelial mitogens, cell proliferation, angiogenesis, and an
in¯ammatory process, which ®nally leads to a greatly thickened
epidermal mass (Kadunce and Krueger, 1995). Earlier publications
reported highly elevated phosphocreatine levels and increased CK
activity in psoriatic skin as compared with normal skin (Zemtsov et
al, 1994a, b). In this pilot study, all psoriasis biopsies consistently
showed an upregulation of CRT species, including CRT65, the
likely candidate for the plasma membrane CRT. This could indeed
lead to accumulation of intracellular creatine and ®nally to higher
phosphocreatine concentrations. Our results could not give a
de®nitive answer on changes in CK isoenzyme expression due to
high variability among individuals and a small sample size. uMtCK
would be a good candidate for upregulation, as psoriatic skin
partially switches from glycolytic to oxidative metabolism
(Zemtsov et al, 1994b) and uMtCK is often overexpressed as a
compensatory measure under energy stress, e.g., in aged vs adult
animals (Lee et al, 1999) or patients with mitochondrial disorders
(Heddi et al, 1999). De®nitively, a much broader study is needed to
address this hypothesis.
Taken together, we have obtained good evidence for the
presence of a functional CK/phosphocreatine system in many
metabolically very active cell types in skin, especially in epidermis
and hair follicles. In addition, BB-CK and the CRT65-species most
probably localized in the plasma membrane are upregulated after
injury during cutaneous wound repair and CRT species are also
more abundant in psoriatic skin. It will be important to analyze the
molecular basis of CK and CRT regulation, as well as the
contribution of the CK/phosphocreatine system to epidermal and
hair growth in healthy and injured skin. The fact that postoperative
perfusion of ischemically compromised skin ¯aps with solution
containing phosphocreatine leads to improved survival of such ¯aps
(Cuono et al, 1987) points to important functions of the CK/
phosphocreatine system in skin.
Figure 7. Creatine transporter in healthy and psoriatic human
skin. Immunoblots of protein extracts from human skin biopsies
containing epidermis and dermis. Three samples each of healthy and
psoriatic skin are shown. Forty micrograms of total protein were applied
to each lane and equal loading was veri®ed by Ponceau S staining. Blots
were developed as described in detail in Materials and Methods. Mr for
speci®c bands is indicated.
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